Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma

BACKGROUND: Identification of potential novel targets for reversing resistance to Epidermal Growth Factor Receptor (EGFR)-tyrosine kinase inhibitors (EGFR-TKIs) holds great promise for the treatment of relapsed lung adenocarcinoma (LUAD). In the present study, we aim to investigate the role of methy...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Huibin, Liu, Dongcheng, Wang, Lingwei, Liu, Kaisheng, Chen, Chen, Wang, Le, Ren, Yi, Ju, Bing, Zhong, Fuhua, Jiang, Xingyu, Wang, Guangsuo, Chen, Zhe-Sheng, Zou, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830004/
https://www.ncbi.nlm.nih.gov/pubmed/35144642
http://dx.doi.org/10.1186/s12943-022-01519-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830004/
https://www.ncbi.nlm.nih.gov/pubmed/35144642
http://dx.doi.org/10.1186/s12943-022-01519-7

Ejemplares similares